1 - 4 of 4 Results
Direct-acting antivirals are needed to combat coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).
A novel molecular sorbent system for low energy CO2 regeneration is developed by employing CO2-responsive molecules and salt in aqueous media where a precipitating CO2--salt fractal network is formed, resulting in solid-phase formation and sedimentation.
There is a critical need for new antiviral drugs for treating infections of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).